Onderzoekers van het UMCG en spin‑off CC Diagnostics, lid van de LIFE Cooperative, hebben een nieuwe test ontwikkeld die het screenen op baarmoederhalskanker mogelijk efficiënter en gebruiksvriendelijker maakt. De methode richt zich op het nauwkeuriger opsporen van afwijkende cellen en kan volgens de onderzoekers bijdragen aan een toegankelijker bevolkingsonderzoek.
Researchers at the UMCG and their spin-off CC Diagnostics, located on Campus Groningen, have developed a new test that could make cervical cancer screening more efficient and user-friendly. The method focuses on detecting abnormal cells more accurately and, according to the researchers, could contribute to more accessible population screening.
It is great to see this development taking place at the Healthy Ageing Campus, where research and entrepreneurship come together around innovations that strengthen the health of future generations.
Read the full article in Trouw here .
Source: Trouw, Renée Moezelaar (March 13, 2026).
Vandaag is bekend gemaakt dat ZonMw verwacht in september een nieuwe subsidieoproep binnen de PharmaNL Shared Development Infrastructure (SDI)-programmalijn te openen.
What if a surgeon could tell within five minutes whether a tumour has been completely removed? That is exactly what LIFE Cooperative member SPCTR is working on. In the Groninger Ondernemers Courant, the SPCTR team talks about their groundbreaking technology, which will allow surgeons to see within five minutes whether a tumour has been completely removed.
Following the keynote by Peter Wennink, the conversation continues with a panel discussion in which we will explore the themes from the keynote in further depth and look at the issues from different perspectives.
